AAAAAA

   
Results: 1-25 | 26-50 | 51-72
Results: 1-25/72
MYELOID PROGENITOR-CELL PROLIFERATION AND MOBILIZATION EFFECTS OF BB10010, A GENETICALLY-ENGINEERED VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA, IN A PHASE-I CLINICAL-TRIAL IN PATIENTS WITH RELAPSED REFRACTORY BREAST-CANCER/
Authors: BROXMEYER HE ORAZI A HAGUE NL SLEDGE GW RASMUSSEN H GORDON MS
Citation: He. Broxmeyer et al., MYELOID PROGENITOR-CELL PROLIFERATION AND MOBILIZATION EFFECTS OF BB10010, A GENETICALLY-ENGINEERED VARIANT OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA, IN A PHASE-I CLINICAL-TRIAL IN PATIENTS WITH RELAPSED REFRACTORY BREAST-CANCER/, Blood cells, molecules, & diseases, 24(2), 1998, pp. 14-30
PLATELET DEPLETION DURING PEDIATRIC PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) HARVESTING
Authors: MCCARTHY L SMITH FO EMANUEL D ORAZI A DANIELSON C THOMPSON C THOMAS C KREISSMAN S
Citation: L. Mccarthy et al., PLATELET DEPLETION DURING PEDIATRIC PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) HARVESTING, Transfusion science, 19(1), 1998, pp. 61-61
TREATMENT WITH FLT3 LIGAND TRANSDUCED C3L5 CELLS FOR MURINE BREAST-CANCER
Authors: BRAUN SE CHEN K ORAZI A BROXMEYER HE CORNETTA K
Citation: Se. Braun et al., TREATMENT WITH FLT3 LIGAND TRANSDUCED C3L5 CELLS FOR MURINE BREAST-CANCER, Experimental hematology, 26(8), 1998, pp. 456-456
PROLIFERATION-INDUCED DECLINE OF PRIMITIVE HEMATOPOIETIC PROGENITOR-CELL ACTIVITY IS COUPLED WITH AN INCREASE IN APOPTOSIS OF EX-VIVO EXPANDED CD34(+) CELLS
Authors: TRAYCOFF CM ORAZI A LADD AC RICE S MCMAHEL J SROUR EF
Citation: Cm. Traycoff et al., PROLIFERATION-INDUCED DECLINE OF PRIMITIVE HEMATOPOIETIC PROGENITOR-CELL ACTIVITY IS COUPLED WITH AN INCREASE IN APOPTOSIS OF EX-VIVO EXPANDED CD34(+) CELLS, Experimental hematology, 26(1), 1998, pp. 53-62
SHOULD SPLENECTOMY BE CONSIDERED FOR PATIENTS WITH REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA
Authors: MCCARTHY LJ ORAZI A DANIELSON CFM MIRAGLIA C GREIST A PORCU P CRIPE L GOULET R
Citation: Lj. Mccarthy et al., SHOULD SPLENECTOMY BE CONSIDERED FOR PATIENTS WITH REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA, Transfusion, 38(10), 1998, pp. 8-8
MESOCAVAL SHUNT INHIBITS PRIMARY AND METASTATIC HEPATOMA GROWTH AND ENHANCES APOPTOSIS
Authors: LIU Q KABEER M CALLAHAN M ORAZI A PESCOVITZ MD GROSFELD JL
Citation: Q. Liu et al., MESOCAVAL SHUNT INHIBITS PRIMARY AND METASTATIC HEPATOMA GROWTH AND ENHANCES APOPTOSIS, Journal of pediatric surgery, 33(7), 1998, pp. 1128-1133
COMPARISON OF INTERLEUKIN-11 AND EPIDERMAL GROWTH-FACTOR ON RESIDUAL SMALL-INTESTINE AFTER MASSIVE SMALL-BOWEL RESECTION
Authors: FIORE NF LEDNICZKY G LIU Q ORAZI A DU XX WILLIAMS DA GROSFELD JL
Citation: Nf. Fiore et al., COMPARISON OF INTERLEUKIN-11 AND EPIDERMAL GROWTH-FACTOR ON RESIDUAL SMALL-INTESTINE AFTER MASSIVE SMALL-BOWEL RESECTION, Journal of pediatric surgery, 33(1), 1998, pp. 24-29
THE BCL-6 PROTOONCOGENE CONTROLS GERMINAL-CENTER FORMATION AND TH2-TYPE INFLAMMATION
Authors: YE BH CATTORETTI G SHEN QO ZHANG JD HAWE N DEWAARD R LEUNG C NOURISHIRAZI M ORAZI A CHAGANTI RSK ROTHMAN P STALL AM PANDOLFI PP DALLAFAVERA R
Citation: Bh. Ye et al., THE BCL-6 PROTOONCOGENE CONTROLS GERMINAL-CENTER FORMATION AND TH2-TYPE INFLAMMATION, Nature genetics, 16(2), 1997, pp. 161-170
013-(CD99)-POSITIVITY IN HEMATOLOGIC PROLIFERATIONS CORRELATES WITH TDT POSITIVITY
Authors: ROBERTSON PB NEIMAN RS WORAPONGPAIBOON S JOHN K ORAZI A
Citation: Pb. Robertson et al., 013-(CD99)-POSITIVITY IN HEMATOLOGIC PROLIFERATIONS CORRELATES WITH TDT POSITIVITY, Modern pathology, 10(4), 1997, pp. 277-282
PROTECTIVE EFFECTS OF INTERLEUKIN-11 IN A MURINE MODEL OF ISCHEMIC BOWEL NECROSIS
Authors: DU XX LIU Q YANG ZX ORAZI A RESCORLA FJ GROSFELD JL WILLIAMS DA
Citation: Xx. Du et al., PROTECTIVE EFFECTS OF INTERLEUKIN-11 IN A MURINE MODEL OF ISCHEMIC BOWEL NECROSIS, American journal of physiology: Gastrointestinal and liver physiology, 35(3), 1997, pp. 545-552
CD34 IMMUNOSTAINING, A POTENTIALLY USEFUL TECHNIQUE TO ASSESS MINIMALRESIDUAL DISEASE (MRD) IN CD34(+) ACUTE LEUKEMIAS (AL)
Authors: WORAPONGPAIBOON S SHAPIRA G NEIMAN R HEEREMA N JOHN K ORAZI A
Citation: S. Worapongpaiboon et al., CD34 IMMUNOSTAINING, A POTENTIALLY USEFUL TECHNIQUE TO ASSESS MINIMALRESIDUAL DISEASE (MRD) IN CD34(+) ACUTE LEUKEMIAS (AL), Laboratory investigation, 76(1), 1997, pp. 796-796
DETECTION OF METASTATIC NEUROBLASTOMA (NB) IN STAGING BONE-MARROW (BM) SPECIMENS, A HISTOLOGICAL AND IMMUNOHISTOCHEMICAL (IHC) ANALYSIS
Authors: AHSAN A ORAZI A NEIMAN R
Citation: A. Ahsan et al., DETECTION OF METASTATIC NEUROBLASTOMA (NB) IN STAGING BONE-MARROW (BM) SPECIMENS, A HISTOLOGICAL AND IMMUNOHISTOCHEMICAL (IHC) ANALYSIS, Laboratory investigation, 76(1), 1997, pp. 910-910
THERAPEUTIC LEUKAPHERESIS IN HYPERLEUCOCYTIC LEUKEMIAS - LACK OF CORRELATION BETWEEN DEGREE OF CYTOREDUCTION AND EARLY MORTALITY-RATE
Authors: PORCU P DANIELSON CF ORAZI A HEEREMA NA GABIG TG MCCARTHY LJ
Citation: P. Porcu et al., THERAPEUTIC LEUKAPHERESIS IN HYPERLEUCOCYTIC LEUKEMIAS - LACK OF CORRELATION BETWEEN DEGREE OF CYTOREDUCTION AND EARLY MORTALITY-RATE, British Journal of Haematology, 98(2), 1997, pp. 433-436
LEUKEMIC MENINGITIS COMPLICATING EARLY-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: MILLER K BUDKE H ORAZI A
Citation: K. Miller et al., LEUKEMIC MENINGITIS COMPLICATING EARLY-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA, Archives of pathology and laboratory medicine, 121(5), 1997, pp. 524-527
POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS IN BONE-MARROW TRANSPLANT RECIPIENTS ARE AGGRESSIVE DISEASES WITH A HIGH-INCIDENCE OF ADVERSE HISTOLOGIC AND IMMUNOBIOLOGICAL FEATURES
Authors: ORAZI A HROMAS RA NEIMAN RS GREINER TC LEE CH RUBIN L HASKINS S HEEREMA NA GHARPURE V ABONOUR R SROUR EF CORNETTA K
Citation: A. Orazi et al., POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS IN BONE-MARROW TRANSPLANT RECIPIENTS ARE AGGRESSIVE DISEASES WITH A HIGH-INCIDENCE OF ADVERSE HISTOLOGIC AND IMMUNOBIOLOGICAL FEATURES, American journal of clinical pathology, 107(4), 1997, pp. 419-429
HYPOPLASTIC MYELODYSPLASTIC SYNDROMES CAN BE DISTINGUISHED FROM ACQUIRED APLASTIC-ANEMIA BY CD34 AND PCNA IMMUNOSTAINING OF BONE-MARROW BIOPSY SPECIMENS
Authors: ORAZI A ALBITAR M HEEREMA NA HASKINS S NEIMAN RS
Citation: A. Orazi et al., HYPOPLASTIC MYELODYSPLASTIC SYNDROMES CAN BE DISTINGUISHED FROM ACQUIRED APLASTIC-ANEMIA BY CD34 AND PCNA IMMUNOSTAINING OF BONE-MARROW BIOPSY SPECIMENS, American journal of clinical pathology, 107(3), 1997, pp. 268-274
BIOLOGICAL DETERMINANTS OF LONG-TERM SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH CONVENTIONAL CHEMOTHERAPY
Authors: FOA P IURLO A ORAZI A SAGLIO G RIBERA S BERTONI F CALDIERA S FORNIER M MAIOLO AT
Citation: P. Foa et al., BIOLOGICAL DETERMINANTS OF LONG-TERM SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH CONVENTIONAL CHEMOTHERAPY, Acta haematologica, 97(3), 1997, pp. 187-188
PLATELET LOSS DURING PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS
Authors: MCCARTHY LJ DANIELSON C ORAZI A SKIPWORTH E JACKSON L GRAVES V GHARPURE V CORNETTA K
Citation: Lj. Mccarthy et al., PLATELET LOSS DURING PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS, Transfusion science, 17(3), 1996, pp. 475-475
MDM-2 ONCOPROTEIN EXPRESSION ASSOCIATED WITH DELETION OF THE LONG ARMOF CHROMOSOME-12 IN A CASE OF MANTLE CELL LYMPHOMA WITH BLASTOID TRANSFORMATION (VOL 9, PG 355, 1996)
Authors: HAIDAR JH NEIMAN RS ORAZI A ALBITAR M MCCARTHY LJ HEEREMA N
Citation: Jh. Haidar et al., MDM-2 ONCOPROTEIN EXPRESSION ASSOCIATED WITH DELETION OF THE LONG ARMOF CHROMOSOME-12 IN A CASE OF MANTLE CELL LYMPHOMA WITH BLASTOID TRANSFORMATION (VOL 9, PG 355, 1996), Modern pathology, 9(7), 1996, pp. 803-803
MDM-2 ONCOPROTEIN EXPRESSION IN MANTLE CELL LYMPHOMA WITH BLASTOID TRANSFORMATION
Authors: HAIDAR JH NEIMAN RS ORAZI A ALBITAR M MCCARTHY LJ HEEREMA N
Citation: Jh. Haidar et al., MDM-2 ONCOPROTEIN EXPRESSION IN MANTLE CELL LYMPHOMA WITH BLASTOID TRANSFORMATION, Modern pathology, 9(4), 1996, pp. 355-359
P53 OVEREXPRESSION IN MYELOID LEUKEMIC DISORDERS IS ASSOCIATED WITH INCREASED APOPTOSIS OF HEMATOPOIETIC MARROW-CELLS AND INEFFECTIVE HEMATOPOIESIS
Authors: ORAZI A KAHSAI M JOHN K NEIMAN RS
Citation: A. Orazi et al., P53 OVEREXPRESSION IN MYELOID LEUKEMIC DISORDERS IS ASSOCIATED WITH INCREASED APOPTOSIS OF HEMATOPOIETIC MARROW-CELLS AND INEFFECTIVE HEMATOPOIESIS, Modern pathology, 9(1), 1996, pp. 48-52
PROTECTIVE EFFECTS OF INTERLEUKIN-11 (IL-11) IN MURINE THROMBOCYTOPENIA DUE TO ISCHEMIC BOWEL NECROSIS
Authors: DU XX LIU Q YANG ZH ORAZI A RESCOLA FJ GROSFELD JL WILLIAMS DA
Citation: Xx. Du et al., PROTECTIVE EFFECTS OF INTERLEUKIN-11 (IL-11) IN MURINE THROMBOCYTOPENIA DUE TO ISCHEMIC BOWEL NECROSIS, Experimental hematology, 24(9), 1996, pp. 433-433
EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) ON MEGAKARYOCYTOPOIESIS IN HUMAN BONE-MARROW
Authors: ORAZI A COOPER RJ TONG J GORDON MS BATTIATO L SLEDGE GW KAYE JA KAHSAI M HOFFMAN R
Citation: A. Orazi et al., EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-11 (NEUMEGA(TM) RHIL-11 GROWTH-FACTOR) ON MEGAKARYOCYTOPOIESIS IN HUMAN BONE-MARROW, Experimental hematology, 24(11), 1996, pp. 1289-1297
PRO-VS-ANTI-CD45
Authors: NEIMAN RS ORAZI A
Citation: Rs. Neiman et A. Orazi, PRO-VS-ANTI-CD45, The American journal of surgical pathology, 20(4), 1996, pp. 507-508
LOSS-OF-NORMAL-FEEDWATER SENSITIVITY STUDIES FOR AP600 BEHAVIOR CHARACTERIZATION
Authors: SAIU G DELNERO G MADONNA A MARELLA G ORAZI A
Citation: G. Saiu et al., LOSS-OF-NORMAL-FEEDWATER SENSITIVITY STUDIES FOR AP600 BEHAVIOR CHARACTERIZATION, Nuclear technology, 115(3), 1996, pp. 320-332
Risultati: 1-25 | 26-50 | 51-72